Prevalence and Outcomes of Patients With Acute Ischemic Stroke and Concomitant Non–ST-Elevation Myocardial Infarction (Results from the National Inpatient Sample 2016 to 2019)

Shivani Mehta, Roxana Mehran, Shahzad Hassan, Jasmeet Kaur, Anupam Sule, Camelia Arsene, Geetha Krishnamoorthy, Moyses Szklo

Research output: Contribution to journalArticlepeer-review

Abstract

Acute myocardial infarction (MI) may concomitantly occur with acute ischemic stroke. The incidence and outcomes of acute non–ST-elevation MI (NSTEMI) in acute ischemic stroke are not well studied. We examined hospitalized patients with acute ischemic stroke and a concomitant NSTEMI diagnosis who were included in the National Inpatient Sample 2016 to 2019. Acute ischemic stroke and NSTEMI were defined by using the International Classification of Diseases, Tenth Revision codes. Patients with ST-elevation MI were excluded. The outcomes were expressed as percentages. A multivariable logistic regression analysis was used to examine the association of concomitant acute ischemic stroke and NSTEMI with the primary outcome of mortality and the secondary outcomes. A subgroup analysis of patients with NSTEMI with acute ischemic stroke that underwent percutaneous coronary intervention (PCI) (angiography and angioplasty) was also performed. Of the total hospitalized patients with acute ischemic stroke (n = 1,726,265), 1.60% (n = 27,630) patients (mean age 73.5 years, 52.2% women, 67% White race) had NSTEMI diagnosed during the hospitalization. Of these, 14.1% (n = 3,890) died in the NSTEMI group and 3.4% (n = 57,670) died in the non-NSTEMI group. The most common outcomes in the NSTEMI group were Acute kidney injury 31.8%, Intracranial hemorrhage 6.6%, and sepsis 6.13%. NSTEMI in acute ischemic stroke was associated with mortality (odds ratio [OR] 3.60, 95% confidence interval [CI] 3.29 to 3.93, p ≤0.001), ICH (OR 1.46, 95% CI 1.30 to 1.63, p <0.001), and having any of the secondary outcomes (OR 2.73, 95% CI 2.57 to 2.90, p <0.001). PCI was performed in 9.14% of patients with acute ischemic stroke with NSTEMI. PCI was associated with having any of the secondary outcomes (OR 0.83, 95% CI 0.7 to 1.02, p = 0.8), mortality (OR 0.35, 95% CI 0.23 to 0.54, p <0.001), and ICH (OR 0.42, 95% CI 0.25 to 0.7, p = 0.01). In conclusion, NSTEMI in acute ischemic stroke is associated with increased mortality and other adverse events. PCI in the subgroup of patients with NSTEMI was not associated with increased mortality or intracranial bleeding.

Original languageEnglish
Pages (from-to)346-353
Number of pages8
JournalAmerican Journal of Cardiology
Volume205
DOIs
StatePublished - 15 Oct 2023

Keywords

  • NSTEMI
  • cerebrovascular accident
  • stroke

Fingerprint

Dive into the research topics of 'Prevalence and Outcomes of Patients With Acute Ischemic Stroke and Concomitant Non–ST-Elevation Myocardial Infarction (Results from the National Inpatient Sample 2016 to 2019)'. Together they form a unique fingerprint.

Cite this